Tranquilli Financial Advisor’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,257
Closed -$326K 118
2024
Q4
$326K Sell
2,257
-33
-1% -$5.11K 0.21% 83
2024
Q3
$371K Sell
2,290
-16
-0.7% -$2.55K 0.23% 79
2024
Q2
$338K Sell
2,306
-2
-0.1% -$297 0.23% 81
2024
Q1
$365K Buy
2,308
+260
+13% +$41.4K 0.24% 79
2023
Q4
$321K Sell
2,048
-99
-5% -$15.2K 0.23% 80
2023
Q3
$334K Sell
2,147
-146
-6% -$24.1K 0.24% 71
2023
Q2
$380K Buy
2,293
+26
+1% +$4.2K 0.27% 65
2023
Q1
$351K Buy
2,267
+141
+7% +$22.8K 0.26% 68
2022
Q4
$376K Buy
2,126
+24
+1% +$4.14K 0.29% 62
2022
Q3
$343K Buy
2,102
+76
+4% +$12.9K 0.27% 47
2022
Q2
$360K Buy
2,026
+89
+5% +$15.9K 0.28% 41
2022
Q1
$343K Buy
1,937
+148
+8% +$25.2K 0.24% 60
2021
Q4
$306K Buy
1,789
+8
+0.4% +$1.31K 0.21% 68
2021
Q3
$288K Hold
1,781
0.22% 64
2021
Q2
$293K Sell
1,781
-3
-0.2% -$497 0.22% 65
2021
Q1
$293K Hold
1,784
0.24% 60
2020
Q4
$281K Buy
+1,784
New +$263K 0.26% 56

Other funds holding JNJ

Tranquilli Financial Advisor's JNJ Position: Q1 2025 in Review

Tranquilli Financial Advisor sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 2,257 shares — an estimated $326K sold.

Tranquilli Financial Advisor first reported a position in JNJ in Q4 2020 and held it in 17 quarters. The position peaked at $380K in Q2 2023. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Tranquilli Financial Advisor reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Tranquilli Financial Advisor sold 2,257 Johnson & Johnson shares in Q1 2025, an estimated $326K.
  • Tranquilli Financial Advisor first reported a position in Johnson & Johnson in Q4 2020 and held it in 17 quarters.
  • Tranquilli Financial Advisor's Johnson & Johnson position peaked at $380K in Q2 2023.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Tranquilli Financial Advisor's 13F filing for Q1 2025, filed 12 May 2025.